Dr Reddys Laboratories (RDY) Revenue Growth (5y) (2014 - 2023)
Dr Reddys Laboratories (RDY) Revenue Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.80 Bn | 9.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 9.58% |
| Mar 31, 2023 | 9.59% |
| Dec 31, 2022 | 8.25% |
| Sep 30, 2022 | 1,597.28% |
| Mar 31, 2021 | 3.55% |
| Sep 30, 2020 | 2.42% |
| Jun 30, 2020 | 1.96% |
| Sep 30, 2019 | 0.13% |
| Mar 31, 2019 | -1.48% |
| Dec 31, 2018 | 0.03% |
| Sep 30, 2018 | -0.50% |
| Jun 30, 2018 | -56.48% |
| Mar 31, 2018 | 15.09% |
| Dec 31, 2017 | -3.39% |
| Sep 30, 2017 | 2.31% |
| Dec 31, 2016 | -53.48% |
| Sep 30, 2016 | -61.62% |
| Mar 31, 2016 | 4.64% |
| Dec 31, 2015 | 5.21% |
| Sep 30, 2015 | 7.15% |